ALB and Hyperbilirubinemia: In conclusion, the results presented here supports the potential use of albumin infusions in severe acute neonatal hyperbilirubinemia and in Crigler-Najjar patients, to limit/avoid bilirubin neurotoxicity in situations in which ET may be required.